Exact Mass: 294.14985759999996
Exact Mass Matches: 294.14985759999996
Found 227 metabolites which its exact mass value is equals to given mass value 294.14985759999996
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Alosetron
Alosetron is a 5-HT3 antagonist used only for the management of severe diarrhoea-predominant irritable bowel syndrome (IBS) in women. Alosetron has an antagonist action on the 5-HT3 receptors and thus may modulate serotonin-sensitive gastrointestinal (GI) processes. Alosetron was voluntarily withdrawn from the US market in November 2000 by the manufacturer due to numerous reports of severe adverse effects including ischemic colitis, severely obstructed or ruptured bowel, and death. In June 2002, the FDA approved a supplemental new drug application allowing the remarketing of the drug under restricted conditions of use. A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03A - Drugs for functional gastrointestinal disorders > A03AE - Serotonin receptor antagonists C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist > C94726 - 5-HT3 Receptor Antagonist D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D005765 - Gastrointestinal Agents
Sinapoylputrescine
Sinapoylputrescine is found in fruits. Sinapoylputrescine is an alkaloid from Ananas comosus (pineapple). Alkaloid from Ananas comosus (pineapple). Sinapoylputrescine is found in fruits.
Tocopheronic acid
Human metabolite of a-Tocopherol
Tyrosyl-Leucine
Tyrosyl-Leucine is a dipeptide composed of tyrosine and leucine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.
Leucyl-Tyrosine
Leucyl-Tyrosine is a dipeptide composed of leucine and tyrosine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.
Tyrosyl-Isoleucine
Tyrosyl-Isoleucine is a dipeptide composed of tyrosine and isoleucine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.
Isoleucyl-Tyrosine
Isoleucyl-Tyrosine is a dipeptide composed of isoleucine and tyrosine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.
Mono-(2-ethyl-5-hydroxyhexyl) phthalate
Mono-(2-ethyl-5-hydroxyhexyl) phthalate, also known as 40321-99-1 or phthalic acid mono(2-ethyl-5-hydroxyhexyl) ester, is classified as a member of the benzoic acid esters. Benzoic acid esters are ester derivatives of benzoic acid. 40321-99-1 is considered to be practically insoluble (in water) and acidic. (ChemoSummarizer) Mono-(2-ethyl-5-hydroxyhexyl) phthalate is a metabolite of mono(2-ethylhexyl) phthalate (MEHP) and a secondary metabolite of di(2-ethylhexyl) phthalate (DEHP) [Exposome-Explorer]. Di(2-ethylhexyl) phthalate (DEHP) is added to polyvinyl chloride (PVC) plastics used widely in medical devices and toys to impart flexibility and durability (Pubmed: 16332407).
Emmotin B
4-chloro-N-{[1-(dimethylamino)cyclohexyl]methyl}benzamide
2-chloro-N-{[1-(dimethylamino)cyclohexyl]methyl}benzamide
3-chloro-N-{[1-(dimethylamino)cyclohexyl]methyl}benzamide
troxipide
A - Alimentary tract and metabolism > A02 - Drugs for acid related disorders > A02B - Drugs for peptic ulcer and gastro-oesophageal reflux disease (gord) C78276 - Agent Affecting Digestive System or Metabolism > C29701 - Anti-ulcer Agent
botryosphaerin B|rel-(3aS,5aR,6S,9aS,9bR)-1,2,3a,5a,6,7,8,9,9a,9b-decahydro-10a-hydroxy-3a-(hydroxymethyl)-6,9a-dimethyl-2-oxonaphtho[2,1]furan-6-carboxylic acid
4-hydroxy-5-propionyl-1,3-di-O-methyl-2-O-isopentenylpyrogallol
(3aS*,6R*,6aR*,9R*,9aR*,9bR*)-3a,4,5,6,6a,9,9a,9b-octahydro-6,9-dihydroxy-6a-methoxy-6,9-dimethyl-3-methyleneazuleno<4,5-b>furan-2(3H)-one
8beta-hydroxy-8alpha-methoxy-3-oxo-eremophil-1,7(11)-dien-12-oic acid
(3R),(6R)-6-hydroxy-de-O-methyllasiodiplodin|(3R,6S)-6-hydroxy-de-O-methyllasiodiplodin|F7855-2
Me ester-(??)-Phaseic acid|Me ester-楼?脥-楼?脦-Phaseic acid
1-(2,2-Dimethyl-5,6,7-trimethoxy-alpha-chromene-8-yl)ethanol
(1S,2R,5R,6S,7S,8S,10R)-6-hydroxy-2-methoxy-4-oxopseudoguai-11(13)-en-12,8-olide
A pseudoguaianolide with anti-inflammatory activity isolated from the aerial parts of Inula hupehensis.
(3S,12R)-3-hydroxy-1,7-diazatricyclo[10.4.0.(13,7)]heptadecane-11,16,17-trione|(7S,15aR)-decahydro-7-hydroxy-6H-7,11-methano-4H-pyrido[1,2-a][1,7]diazacyclododecine-4,15,16(12H)-trione|alopecurin A
2alpha-methoxy-8alpha-hydroxy-6-oxogermacra-1(10),7(11)-dien-8,12-olide
(E)-3-(3,5-dimethoxy-4-((2R)-methylbutyryloxy)phenyl)prop-2-enol|dichrocephol A
Me ester -(1(10)E,4alpha,6alpha)-15-Hydroxy-1(10),11(13)-germacradien-12,6-olid-14-oic acid|Methyl 15-hydroxy-4betaH-germacra-1(10)E,11(13)-trien-6alpha,12-olide-14-oic acid
4beta-acetoxy-6alpha-hydroxy-1alpha.10betaH-pseudoguaia-11(13)-en-12.8alpha-olide
1beta,10beta-Epoxy-6beta-hydroxy-8beta-methoxyeremophil-7(11)-en-12,8alpha-olide
3,8-dihydroxy-13-methoxy-4(15),10(14)-guaiadien-12,6-olide
6alpha-acetoxy-4beta-hydroxy-1alpha,10betaH-pseudoguaia-11(13)-en-12.8alpha-olide
6-acetyl-2alpha,5-dihydroxy-2-(2-hydroxypropyl)- 3alpha,8-dimethylchroman
arglanilic acid methyl ester|artanoate|methyl(4R,5S,6S,7S,10R)-1-oxo-4,6-dihydroxy-eudesma-2,11(13)-dien-12-oate
(E)-7-(4-methoxy-5-methyl-6-oxopyran-2-yl)-5-methyloct-6-enoic acid
(E)-4-hydroxy-4-[4-oxo-2-[(E)-6-oxohept-1-enyl]cyclopentyl]but-2-enoic acid
alosetron
A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03A - Drugs for functional gastrointestinal disorders > A03AE - Serotonin receptor antagonists C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist > C94726 - 5-HT3 Receptor Antagonist D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D005765 - Gastrointestinal Agents
(E)-7-(4-methoxy-5-methyl-6-oxopyran-2-yl)-5-methyloct-6-enoic acid [IIN-based: Match]
(E)-7-(4-methoxy-5-methyl-6-oxopyran-2-yl)-5-methyloct-6-enoic acid [IIN-based on: CCMSLIB00000846906]
Ile-tyr
A dipeptide formed from L-isoleucine and L-tyrosine residues.
Leu-tyr
A dipeptide formed from L-leucine and L-tyrosine residues.
Tyr-ile
A dipeptide formed from L-tyrosine and L-isoleucine residues.
Tyr-leu
A dipeptide formed from L-tyrosine and L-leucine residues.
Tocopheronic acid
4-Amino-N-(tert-butoxycarbonyl)-L-phenylalanine Methyl Ester
Puromycin aminonucleoside
D009676 - Noxae > D000963 - Antimetabolites D000970 - Antineoplastic Agents Puromycin aminonucleoside (NSC 3056) is the aminonucleoside portion of the antibiotic puromycin, and used in nephrosis animal models[1]. Puromycin aminonucleoside induces apoptosis[2]. Puromycin aminonucleoside is a reversible inhibitor of dipeptidyl peptidase II and cytosol alanyl aminopeptidase[3]. Puromycin aminonucleoside induces secretion of cell migrasome[4].
(S)-tert-butyl3-amino-2-(((benzyloxy)carbonyl)amino)propanoate
1-[2-AMINO-1-(2,5-DIMETHOXY-PHENYL)-ETHYL]-PYRROLIDINE-3-CARBOXYLICACID
1-[2-AMINO-1-(3,4-DIMETHOXY-PHENYL)-ETHYL]-PYRROLIDINE-3-CARBOXYLICACID
tert-butyl 4-(1-cyano-2-ethoxy-2-oxoethylidene)piperidine-1-carboxylate
Methyl 3-fluoro-4-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate
C15H20BFO4 (294.14386020000006)
Methanone, 1,9-diazaspiro[5.5]undec-1-ylphenyl-, hydrochloride (1:1)
Methanone, 1,9-diazaspiro[5.5]undec-9-ylphenyl-, hydrochloride (1:1)
Methyl 2,3-O-Isopropylidene-5-O-benzyl-β-D-ribofuranoside
4-(2-methyl-6-phenyl-5H-pyrrolo[3,2-d]pyrimidin-4-yl)morpholine
2-dibenzofuran-2-yl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
C18H19BO3 (294.14271740000004)
17-ethenyl-2,5,8,11,14-pentaoxabicyclo[13.4.0]nonadeca-1(15),16,18-triene
4-Ethoxycarbonyl-2-fluorobenzeneboronic acid pinacol ester
C15H20BFO4 (294.14386020000006)
Methyl 2-(4-fluoro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetate
C15H20BFO4 (294.14386020000006)
Methyl 4-fluoro-2-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate
C15H20BFO4 (294.14386020000006)
4-[benzotriazol-1-yl(phenyl)methyl]morpholine,4-[benzotriazol-2-yl(phenyl)methyl]morpholine
2-(Dibenzo[b,d]furan-4-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
C18H19BO3 (294.14271740000004)
Methyl 3-(4-aminophenyl)-2-[(tert-butoxycarbonyl)amino]propanoate
6-Amino-4-(2-methylpropyl)-3-phenyl-2,4-dihydropyrano[2,3-c]pyrazole-5-carbonitrile
Puromycin aminonucleoside
D009676 - Noxae > D000963 - Antimetabolites D000970 - Antineoplastic Agents
[3-Carboxy-2-(3,4,5-trihydroxypentanoyloxy)propyl]-trimethylazanium
C12H24NO7+ (294.15526939999995)
1-[(E)-[4-(Dimethylamino)phenyl]methylideneamino]-3-(3-methoxypropyl)thiourea
N-(2,4-dimethoxyphenyl)-3-(4-morpholinyl)propanamide
(E)-7-(4-methoxy-5-methyl-6-oxopyran-2-yl)-5-methyloct-6-enoic acid
N-[(3R,5Z,12S)-2,11-dioxo-10-oxa-1-azabicyclo[10.3.0]pentadec-5-en-3-yl]acetamide
N-butyl-N(2)-[(R)-2-hydroxy-2-phenylacetyl]-L-serinamide
(E)-4-hydroxy-4-[4-oxo-2-[(E)-6-oxohept-1-enyl]cyclopentyl]but-2-enoic acid
MONO(2-ETHYL-5-HYDROXYHEXYL) PHTHALATE
A phthalic acid monoester obtained by formal condensation of one of the carboxy groups of phthalic acid with the primary hydroxy group of 2-ethylhexane-1,5-diol